Country Report Card

Angola

Total population, 2018 (UN Population Division) 30,809,787
Surviving Infants (surviving to 1 year per year), 2018 (UN Population Division) 1,181,147
Child mortality rate (deaths < 5 years per 1000 live births), 2018 (Global Health Observatory) 77.2
Gross National Income (per capita, current US$), 2017 (World Bank) 3,330
No. of districts/territories, 2018 (JRF) 170
Total expenditure on health per capita (PPP Intl $), 2015 (Global Health Observatory) 196
Gov. exp. on Routine Immunization (US$), 2017 (JRF) No report
country flag

COUNTRY DATA

Angola

COMMITMENTS INDICATORS 2015 2016 2017 2018 2019 2020
Governance Is the NITAG fully functional? Data not available Data not available Data not available No No Yes
Has the country established a NITAG? Data not available Data not available Data not available No Yes Yes
Domestic funding Government domestic funding for health as % of GDP 1.40 0.00 0.00 0.00 0.00 0.00
Government funding as % of total immunization funding 0.00 0.00 0.00 94.00 97.00 92.60
Equity Has the country reported district-level stock-out of the DTP or MCV vaccine? Yes No Yes Yes Yes Yes
Does the country conduct vaccine impact assessments for at least one newly-introduced vaccine? Data not available Data not available Data not available No Data not available Data not available
Proportion of districts with 80% or more MCV1 coverage 51.00 39.00 40.00 48.00 47.00 39.00
Proportion of districts with 80% or more DTP3 coverage 51.00 54.00 50.00 65.00 53.00 44.00
Effectiveness and efficiency Has the country sustained DTP3 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained DTP3 coverage of 90% or more for at least 3 years (2018-2020)? No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years (2018-2020)? No
Surveillance Non-measles febrile rash illness rate 1.90 0.81 1.21 0.20 1.90 0.70
NP-AFP rate 4.19 4.03 4.26 3.41 4.39 3.79
Coverage and VPD elimination DTP1 coverage 72.00 74.00 68.00 74.00 67.00 61.00
DTP3 coverage 59.00 59.00 56.00 63.00 57.00 51.00
MCV1 coverage 51.00 45.00 42.00 50.00 51.00 44.00
MCV2 coverage 26.00 26.00 30.00 35.00 45.00 41.00
OPV3 coverage 62.00 58.00 52.00 61.00 56.00 51.00
IPV1 coverage 0.00 0.00 0.00 40.00 43.00 43.00
Has the country introduced HPV vaccine? No No No No No No
Has the country introduced the Hepatitis B birth dose? Yes Yes Yes Yes Yes Yes
Has the country eliminated MNT? No No No No No No
Has the country eliminated Measles? No
Progress on polio Polio transition plan submitted? Yes
Did the country have any cases of WPV or cVDPV from 2015-2018? No
Did the country have any cases of WPV or cVDPV in 2019? Yes
Did the country have any cases of WPV or cVDPV in 2020? Yes
cVDPV cases 0.00 0.00 0.00 0.00 138.00 3.00
Immunization research Does the country have immunization research activities within the current cMYP? (2020) Data not available
Does the country currently have a comprehensive Multi-Year Plan (cMYP) for immunization? (2020) Yes
Advocacy and political will Did the country observe African Vaccination Week or World Immunization Week? Yes Yes Data not available Data not available
Vaccine development and production Does the country currently manufacture vaccines? No
Has the country committed to manufacture vaccines in the next 5 years? No
Does the country have a national strategy or plan to manufacture vaccines? No
Has the country committed to vaccine manufacturing at the highest level? No
Has the country established (and/or is working to establish) a tech transfer hub? No
Has the country set aside funding specifically for local manufacture of vaccines? No
Does the country have regulatory capacity at level 3 or higher, sufficient to oversee vaccine manufacturing? No
Met Target  
Approaching Target  
Off Target  
No Report